PhenomeX Overview
- Year Founded
-
2011
- Status
-
Acquired/Merged
- Employees
-
285
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$109M
- Investors
-
2
PhenomeX General Information
Description
PhenomeX Inc is a functional cell biology company that provides live cell biology research tools which deliver deep insights into cellular function and new perspectives on phenomes.
Contact Information
Website
www.phenomex.comCorporate Office
- 5980 Horton Street
- Second Floor
- Emeryville, CA 94608
- United States
Corporate Office
- 5980 Horton Street
- Second Floor
- Emeryville, CA 94608
- United States
PhenomeX Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 12. Merger/Acquisition | 02-Oct-2023 | $109M | Completed | Generating Revenue/Not Profitable | ||
| 11. Secondary Transaction - Open Market | 19-Nov-2020 | Completed | Generating Revenue | |||
| 10. IPO | 17-Jul-2020 | Completed | Generating Revenue | |||
| 9. Later Stage VC | 01-Jan-2019 | Completed | Generating Revenue | |||
| 8. Later Stage VC (Series E) | 28-Jun-2018 | Completed | Generating Revenue | |||
| 7. Debt - General | 23-May-2018 | Completed | Generating Revenue | |||
| 6. Later Stage VC (Series D) | 08-Nov-2016 | Completed | Generating Revenue | |||
| 5. Later Stage VC (Series C) | 21-Sep-2015 | Completed | Generating Revenue | |||
| 4. Early Stage VC | 21-Apr-2014 | $4.68M | Completed | Generating Revenue | ||
| 3. Early Stage VC (Series A2) | 21-Aug-2012 | $4M | $4.68M | Completed | Startup |
PhenomeX Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series E | ||||||||
| Series D | ||||||||
| Series C | ||||||||
| Series B | ||||||||
| Series A2 | ||||||||
| Series A1 | 3,000,002 | $0.000050 | 8% | $0.17 | $0.17 | 1x | $0.17 | 2.63% |
| Series A | 7,320,000 | $0.000050 | 8% | $0.03 | $0.03 | 1x | $0.03 | 6.42% |
PhenomeX Comparisons
Industry
Financing
Details
PhenomeX Competitors (91)
One of PhenomeX’s 91 competitors is ProMab Biotechnologies, a Corporate Backed or Acquired company based in Richmond, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| ProMab Biotechnologies | Corporate Backed or Acquired | Richmond, CA | ||||
| AbCellera | Formerly VC-backed | Vancouver, Canada | ||||
| BioLegend | Formerly Accelerator/Incubator backed | San Diego, CA | ||||
| ImmunoPrecise Antibodies | Corporation | Fargo, ND | ||||
| Cytovance Biologics | Formerly PE-Backed | Oklahoma City, OK |
PhenomeX Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
PhenomeX Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
PhenomeX Former Investors (23)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| A&E Investments | Venture Capital | Minority | ||
| AME Cloud Ventures | Venture Capital | Minority | ||
| Atinum Investment | Venture Capital | Minority | ||
| Black Diamond Ventures | Venture Capital | Minority | ||
| Bridger Holdings | Venture Capital | Minority |
PhenomeX Investments & Acquisitions (2)
PhenomeX’s most recent deal was a Merger/Acquisition with IsoPlexis for . The deal was made on 21-Mar-2023.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| IsoPlexis | 21-Mar-2023 | Merger/Acquisition | Discovery Tools (Healthcare) | ||
| Optera Therapeutics | 07-Mar-2018 | Joint Venture | Biotechnology |
PhenomeX ESG
Risk Overview
Risk Rating
Updated July, 27, 2023
24.39 | Med Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 15,842
Rank
Percentile
Software & Services
Industry
of 1,106
Rank
Percentile
Enterprise and Infrastructure Software
Subindustry
of 444
Rank
Percentile
PhenomeX Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| IsoPlexis | Branford, CT | 2013 |
PhenomeX FAQs
-
When was PhenomeX founded?
PhenomeX was founded in 2011.
-
Where is PhenomeX headquartered?
PhenomeX is headquartered in Emeryville, CA.
-
What is the size of PhenomeX?
PhenomeX has 285 total employees.
-
What industry is PhenomeX in?
PhenomeX’s primary industry is Drug Discovery.
-
Is PhenomeX a private or public company?
PhenomeX is a Private company.
-
What is the current valuation of PhenomeX?
The current valuation of PhenomeX is .
-
What is PhenomeX’s current revenue?
The current revenue for PhenomeX is .
-
How much funding has PhenomeX raised over time?
PhenomeX has raised $394M.
-
Who are PhenomeX’s investors?
A&E Investments, AME Cloud Ventures, Atinum Investment, Black Diamond Ventures, and Bridger Holdings are 5 of 23 investors who have invested in PhenomeX.
-
Who are PhenomeX’s competitors?
ProMab Biotechnologies, AbCellera, BioLegend, ImmunoPrecise Antibodies, and Cytovance Biologics are some of the 91 competitors of PhenomeX.
-
When was PhenomeX acquired?
PhenomeX was acquired on 02-Oct-2023.
-
Who acquired PhenomeX?
PhenomeX was acquired by Bruker.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
